Adding perioperative tislelizumab to neoadjuvant chemotherapy and surgery can improve outcomes in patients with NSCLC, a phase 3 trial suggests.

mtFIT-based screening could reduce incidence of colorectal cancer by 21 percent and associated mortality by 18 percent.

Researchers weighed the evidence in the literature that supports nipple-areola complex restoration with tattoo in women who have undergone breast reconstruction after cancer treatment.

The kinase inhibitor was previously approved for this indication under the FDA’s accelerated pathway based on overall response rate and duration of response.

Researchers sought to determine whether treatment of relapsed/refractory CLL or SLL with venetoclax plus obinutuzumab would lead to durable responses.

Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.

Researchers found that greater exposure to nitrogen dioxide is associated with an increased risk of uterine cancer.

Researchers explored the factors that influence sleep quality in patients with hepatocellular cancer undergoing TACE.

New research suggests that hypofractionated radiotherapy and conventional fractionated radiotherapy largely produce similar outcomes in patients who have undergone breast cancer surgery.